Fresenius Restructures to Focus on High-Growth Platforms Fresenius SE announced plans to reduce its stake in Fresenius Medical Care, reallocating €1.1 billion to strengthen its balance sheet and invest in growth platforms. By focusing on specialized biopharma, medtech, and care provision, the company aims to streamline operations and capitalize on market opportunities worth up to €1 trillion.7